Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

477
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and management of different types of bacillary layer detachment in eyes with rhegmatogenous retinal detachment.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

The Side-Steamroll: a Modified Steamroller Maneuver to Control Fluid Displacement After Pneumatic Retinopexy.

Retinal cases & brief reports·2026
Same author

Marginal Outer Retinal Ridge Following Rhegmatogenous Retinal Detachment Repair: A Novel Biomarker of Retinal Displacement.

Ophthalmology. Retina·2026
Same author

Associations of age-related macular degeneration and statin use: a cross-sectional analysis.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation-Treated Eyes With Proliferative Diabetic Retinopathy.

Journal of vitreoretinal diseases·2026
Same author

Risk of Retinal Detachment After Intravitreal Injection of Anti-VEGF: A Systematic Review and Meta-Analysis.

American journal of ophthalmology·2026
Same journal

Painless Blindness With Conflicting Clues.

JAMA ophthalmology·2026
Same journal

Promise and Pitfalls of Artificial Intelligence Smart Glasses in Low Vision Care.

JAMA ophthalmology·2026
Same journal

Diabetic Retinal Disease Beginning in Childhood.

JAMA ophthalmology·2026
Same journal

Peripapillary Unilateral Retinal Pigment Epithelium Dysgenesis.

JAMA ophthalmology·2026
Same journal

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical Trial.

JAMA ophthalmology·2026
Same journal

The Retina Clinic as a Window Into Systemic Vascular Health.

JAMA ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Jul 18, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.2K

In-Office Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment Repair.

Rajeev H Muni1,2,3,4, Isabela Martins Melo1,2, Aurora Pecaku1,2

  • 1Department of Ophthalmology, St Michael's Hospital/Unity Health Toronto, Toronto, Ontario, Canada.

JAMA Ophthalmology
|August 24, 2023
PubMed
Summary
This summary is machine-generated.

In-office suprachoroidal viscopexy (SCVEXY) offers a minimally invasive repair for rhegmatogenous retinal detachment (RRD). This technique successfully reattached the macula within 24 hours, showing potential for RRD treatment.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 18, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.2K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

2.8K

Area of Science:

  • Ophthalmology
  • Retinal Surgery

Background:

  • Rhegmatogenous retinal detachment (RRD) requires timely intervention to prevent vision loss.
  • Current RRD treatments often involve incisions, tamponade agents, or specific patient positioning.
  • Minimally invasive techniques are sought to improve RRD repair outcomes.

Purpose of the Study:

  • To describe the in-office suprachoroidal viscopexy (SCVEXY) technique for RRD repair.
  • To evaluate the feasibility and initial outcomes of SCVEXY in a clinical setting.

Main Methods:

  • A single-case report detailing the SCVEXY procedure for a fovea-off RRD in a pseudophakic patient.
  • Utilized a 30-gauge needle with a custom guard to inject 1% sodium hyaluronate into the suprachoroidal space.
  • Performed laser retinopexy in the suspected tear region.

Main Results:

  • Successful in-office SCVEXY achieved visible choroidal indentation.
  • Macular reattachment occurred in under 24 hours with no postoperative abnormalities.
  • Optical coherence tomography confirmed viscoelastic material in the suprachoroidal space and rapid recovery of outer retinal bands.

Conclusions:

  • In-office SCVEXY is a feasible technique for creating a temporary choroidal buckle in RRD repair.
  • The procedure is minimally invasive and may enhance anatomical and functional outcomes without fluid drainage or gas tamponade.
  • Further research is necessary to establish the efficacy, safety, and optimal patient selection for SCVEXY.